Hyperfine, Inc.
HYPR · Electromedical & Electrotherapeutic Apparatus · 72.4M shares · +170%/yr ↑ dilution · EDGAR filings ↗
Reference price $1.65 · est. market cap ~$119M — last insider sale, 2026-05-26 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D47Hyperfine — portable-MRI (Swoop) device maker running losses.
Strengths
- Strong liquidity (current 4.3); differentiated point-of-care MRI
Risks
- Operating margin -273%; ongoing cash burn (~4.8q runway)
- Adoption-pace and reimbursement risk
Notable findings
- Net lossNet loss (net margin -262.3%)
- Cash burnNegative free cash flow (-29.1M)
- Material weakness• If we experience material weaknesses in our internal control over financial reporting or otherwise fail to maintain an effective system of internal controls in the future, we may not be able to repo
- Chronic dilutionShare count +170%/yr over 3y (dilution, book value/share -98%)
- Revenue declineRevenue -26.3% YoY
- Insider sellingInsider selling — 5 open-market sale(s) by 2 insider(s) (cluster of 2 insiders, last 6mo) Form 4 ↗
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
49.8%
Operating margin
-273.4%
Net margin
-262.3%
Return on equity
-86.8%
Return on assets
-64.4%
Revenue growth (QoQ)
-26.3%
Current ratio
4.3×
Free cash flow
-$29M
Tangible book value
$41M
Cash & investments
$35M
Cash runway
5q
Stock comp / revenue
20.7%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-26 | HALE BRETT | Sell | 6.0K | $1.65 |
| 2026-05-26 | TEISSEYRE THOMAS | Sell | 6.0K | $1.65 |
| 2026-03-31 | HALE BRETT | Grant | 330K | — |
| 2026-03-31 | TEISSEYRE THOMAS | Grant | 330K | — |
| 2026-03-31 | Sainz Maria | Grant | 750K | — |
| 2026-03-23 | TEISSEYRE THOMAS | Sell | 24K | $1.21 |
| 2026-03-23 | HALE BRETT | Sell | 24K | $1.21 |
| 2026-02-13 | TEISSEYRE THOMAS | Sell | 821 | $1.11 |
| 2025-11-19 | TEISSEYRE THOMAS | Sell | 1.4K | $1.08 |
| 2025-08-18 | TEISSEYRE THOMAS | Sell | 1.2K | $1.33 |
| 2025-05-16 | TEISSEYRE THOMAS | Sell | 2.8K | $0.58 |
| 2025-03-31 | TEISSEYRE THOMAS | Grant | 300K | — |
| 2025-03-31 | HALE BRETT | Grant | 300K | — |
| 2025-02-20 | TEISSEYRE THOMAS | Sell | 3.2K | $1.08 |
| 2025-02-18 | TEISSEYRE THOMAS | Sell | 3.2K | $1.20 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-05-21 | Shareholder vote | filing ↗ |
| 2026-05-12 | ResultsExhibits | filing ↗ |
| 2026-03-18 | Material agreementDebt obligation3.02Exhibits | filing ↗ |
| 2026-03-18 | ResultsExhibits | filing ↗ |
| 2026-01-12 | ResultsReg FDExhibits | filing ↗ |
| 2025-12-29 | Material agreementOtherExhibits | filing ↗ |
| 2025-11-13 | ResultsExhibits | filing ↗ |
| 2025-10-16 | Material agreementOtherExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-21 | 2026-05-21 | 0001193125-26-234426 ↗ |
| 10-Q | 2026-05-12 | 2026-03-31 | 0001193125-26-219428 ↗ |
| 8-K | 2026-05-12 | 2026-05-12 | 0001193125-26-219380 ↗ |
| 10-K | 2026-03-18 | 2025-12-31 | 0001193125-26-114044 ↗ |
| 8-K | 2026-03-18 | 2026-03-18 | 0001193125-26-113996 ↗ |
| 8-K | 2026-03-18 | 2026-03-18 | 0001193125-26-113960 ↗ |
| 8-K | 2026-01-12 | 2026-01-12 | 0001193125-26-009859 ↗ |
| 8-K | 2025-12-29 | 2025-12-29 | 0001193125-25-335370 ↗ |
| 8-K | 2025-11-13 | 2025-11-13 | 0001193125-25-280181 ↗ |
| 10-Q | 2025-11-13 | 2025-09-30 | 0001193125-25-280212 ↗ |
| 8-K | 2025-10-16 | 2025-10-15 | 0001193125-25-241438 ↗ |
| 8-K | 2025-10-15 | 2025-10-15 | 0001193125-25-240255 ↗ |